Global estimates on the number of people blind or visually impaired by diabetic retinopathy: A meta-analysis from 1990 to 2010

Diabetes Care

Volumn 39, Issue 9, 2016, Pages 1643-1649

  Leasher, Janet L ^a   Bourne, Rupert R A ^b   Flaxman, Seth R ^c   Jonas, Jost B ^d   Keeffe, Jill ^e   Naidoo, Kovin ^f,g   Pesudovs, Konrad ^h   Price, Holly ^b   White, Richard A ⁱ   Wong, Tien Y ^j   Resnikoff, Serge ^g   Taylor, Hugh R ^k  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

^c Carnegie Mellon University ^*  (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e L V PRASAD EYE INSTITUTE   (India)

^f UNIVERSITY OF KWAZULU NATAL   (South Africa)

^g BRIEN HOLDEN VISION INSTITUTE   (Australia)

^h FLINDERS UNIVERSITY   (Australia)

ⁱ NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^j NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^k UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA SOUTH OF THE SAHARA; AGE; ARTICLE; AUSTRALIA AND NEW ZEALAND; BLINDNESS; DIABETIC RETINOPATHY; DISEASE SEVERITY; EAST ASIAN; HIGHEST INCOME GROUP; HUMAN; NORTH AMERICA; PREVALENCE; SOUTH ASIA; SOUTHEAST ASIA; TREND STUDY; VISUAL ACUITY; VISUAL IMPAIRMENT; WESTERN EUROPE; AFRICA; ASIA; COMPLICATION; EUROPE; GLOBAL DISEASE BURDEN; GLOBAL HEALTH; META ANALYSIS; STATISTICS AND NUMERICAL DATA; VISION DISORDERS; VISUALLY IMPAIRED PERSON;

AFRICA; ASIA; AUSTRALASIA; BLINDNESS; DIABETIC RETINOPATHY; EUROPE; GLOBAL BURDEN OF DISEASE; GLOBAL HEALTH; HUMANS; NORTH AMERICA; PREVALENCE; VISION DISORDERS; VISUAL ACUITY; VISUALLY IMPAIRED PERSONS;

EID: 84986203205     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-2171     Document Type: Article

References (38)

1. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102: 527-532
2. Mitchell P, Smith W, Wang JJ, Attebo K. Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology 1998;105:406-411
3. Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Rao GN. Population based assessment of diabetic retinopathy in an urban population in southern India. Br J Ophthalmol 1999; 83:937-940
4. Leske MC, Wu SY, Hyman L, et al. Diabetic retinopathy in a black population: The Barbados Eye Study. Ophthalmology 1999;106:1893-1899
5. McKay R, McCarty CA, Taylor HR. Diabetic retinopathy in Victoria, Australia: The Visual Impairment Project. Br J Ophthalmol 2000;84: 865-870
6. West SK, Klein R, Rodriguez J, et al.; Proyecto VER. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care 2001;24:1204-1209
7. Tapp RJ, Shaw JE, Harper CA, et al.; AusDiab Study Group. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003;26: 1731-1737
8. Varma R, Torres M, Pena F, Klein R, Azen SP; Los Angeles Latino Eye Study Group. Prevalence of diabetic retinopathy in adult Latinos: The Los Angeles Latino Eye Study. Ophthalmology 2004; 111:1298-1306
9. Kempen JH, O'Colmain BJ, Leske MC, et al.; Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004;122:552-563
10. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci 2005;46:2328-2333
11. Wong TY, Klein R, Islam FM, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 2006;141: 446-455
12. Xu L, Wang Y, Li Y, et al. Causes of blindness and visual impairment in an urban and rural area in Beijing: The Beijing Eye Study. Ophthalmology 2006;113:1141.e1-1141.e3
13. Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 2007;14:179-183
14. Wong TY, Cheung N, Tay WT, et al. Prevalence and risk factors for diabetic retinopathy: The Singapore Malay Eye Study. Ophthalmology 2008;115:1869-1875
15. Namperumalsamy P, Kim R, Vignesh TP, et al. Prevalence and risk factors for diabetic retinopathy: A population-based assessment from Theni District, south India. Br J Ophthalmol 2009;93:429-434
16. Raman R, Rani PK, Reddi Rachepalle S, et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology 2009;116:311-318
17. Wang FH, Liang YB, Zhang F, et al. Prevalence of diabetic retinopathy in rural China: The Handan Eye Study. Ophthalmology 2009;116: 461-467
18. Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005 2008. JAMA 2010;304:649-656
19. Jonas JB, Nangia V, Khare A, et al. Prevalence and associated factors of diabetic retinopathy in rural central India. Diabetes Care 2013; 36:e69
20. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010;376:124-136
21. Yau JW, Rogers SL, Kawasaki R, et al.;Meta- Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35: 556-564
22. Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep 2012;12:346-354
23. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82:844-851
24. Stevens GA, White RA, Flaxman SR, et al.; Vision Loss Expert Group. Global prevalence of vision impairment and blindness: Magnitude and temporal trends, 1990 2010. Ophthalmology 2013;120:2377-2384
25. Bourne RR, Stevens GA, White RA, et al.; Vision Loss Expert Group. Causes of vision loss worldwide, 1990-2010: A systematic analysis. Lancet Glob Health 2013;1:e339-e349
26. Bourne R, Price H, Taylor H, et al.; Global Burden of Disease Vision Loss Expert Group. New systematic review methodology for visual impairment and blindness for the 2010 Global Burden of Disease study. Ophthalmic Epidemiol 2013;20:33-39
27. Murray CJ, Vos T, Lozano R, et al. Disabilityadjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-2223
28. AhmadO, Boschi-Pinto C, Lopez AD, et al. Age Standardization of Rates: A New WHO Standard. Geneva, World Health Org., 2001
29. Lansingh VC, Resnikoff S, Tingley-Kelley K, et al. Cataract surgery rates in latin america: A four-year longitudinal study of 19 countries. Ophthalmic Epidemiol 2010;17:75-81
30. Jonas JB, Kamppeter BA, Harder B, Vossmerbaeumer U, Sauder G, Spandau UH. Intravitreal triamcinolone acetonide for diabetic macular edema: A prospective, randomized study. J Ocul Pharmacol Ther 2006;22: 200-207
31. Elman MJ, Qin H, Aiello LP, et al.; Diabetic Retinopathy Clinical Research Network. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: Three-year randomized trial results. Ophthalmology 2012;119:2312-2318
32. Jaffiol C. The burden of diabetes in Africa: A major public health problem. Bull Acad Natl Med 2011;195:1239-1253; discussion 1253-1254 [in French]
33. He L, Tuomilehto J, Qiao Q, et al.; DECODA study group. Impact of classical risk factors of type 2 diabetes among Asian Indian, Chinese and Japanese populations. Diabetes Metab. 2015;41:401-409
34. Danaei G, Finucane MM, Lu Y, et al.; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 countryyears and 2z7 million participants. Lancet 2011;378:31-40
35. World Health Organization. Coding instructions for the WHO/PBL eye examination record (version III). PBL/88.1 [Internet]. Available from http://apps.who.int/iris/bitstream/10665/ 67896/1/PBL-88.1.pdf. Accessed 5 September 2015
36. Kempen JH. The need for a revised approach to epidemiological monitoring of the prevalence of visual impairment. Ophthalmic Epidemiol 2011;18:99-102
37. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012; 96:614-618
38. Mitchell P, Wong TY; Diabetic Macular Edema Treatment Guideline Working Group. Management paradigms for diabetic macular edema. Am J Ophthalmol 2014;157:505 513. e1-e8.